 |
 | Services
| |
 |
Aliases & Descriptions for C3
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc
, and/or 7Ensembl,
8miRBase) About This Section
|
| Aliases |
|---|
| ARMD9 2, 5 | | ASP 2 | | CPAMD1 1, 2, 3 |
| | | Descriptions |
|---|
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1 3 | | acylation-stimulating protein cleavage product 2 | | complement component 3 2 | | complement component C3 2 |
|
| | Search outside databases for aliases for C3 genePrevious GC identifers: GC19M006772 GC19M006617 |
Summaries for C3(According to Entrez Gene,
Wikipedia's
Gene Wiki,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| EntrezGene summary for C3: Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. People with C3 deficiency are susceptible to bacterial infection. [provided by RefSeq] UniProtKB/Swiss-Prot: CO3_HUMAN, P01024Function: Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytesGene Wiki entry for C3 (Complement_component_3) |
Genomic Location for C3
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 36),
and/or miRBase,
Genomic Views according to
UCSC and
Ensembl,
Transcription factor binding sites according to
SABiosciences) About This Section
| Genomic View: UCSC Golden Path with GeneCards custom track
Transcription factor binding sites upstream to the C3 gene 
Entrez Gene cytogenetic band: 19p13.3-p13.2 Ensembl cytogenetic band: 19p13.3 HGNC cytogenetic band: 19p13.3-p13.2C3 Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)
 GeneLoc gene densities for chromosome 19 GeneLoc Exon Structure GeneLoc location for GC19M006628:
(about GC identifiers)
Start:
|
6,628,846 bp from pter |
End:
|
6,671,662 bp from pter |
Size:
|
42,817 bases |
Orientation:
|
minus strand |
RefSeq DNA sequence:- NC_000019.8 NT_011255.14
| Proteins for C3
(According to
1UniProtKB,
and/or Ensembl,
Phosphorylation sites according to 2Phosphosite,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Enzo Life Sciences,
Abnova,
OriGene and/or,
Abcam,
Biochemical Assays by
Invitrogen,
Millipore,
R&D Systems,
Cell Signaling Technology, and/or
Enzo Life Sciences,
Ontologies according to Gene
Ontology Consortium 01 Apr 2009 and
Entrez Gene,
Antibodies by Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Cell Signaling Technology,
Abcam,
Abnova, and/or
Novus Biologicals)
About This Section
| UniProtKB/Swiss-Prot: CO3_HUMAN, P01024 (See
protein sequence)Recommended Name: Complement C3 precursor Size: 1663 amino acids; 187148 Da
Subunit: C3 precursor is first processed by the removal of 4 Arg residues, forming two chains, beta and alpha, linked by a disulfide bond. C3 convertase activates C3 by cleaving the alpha chain, releasing C3a anaphylatoxin and generating C3b (beta chain + alpha' chain). During pregnancy, C3dg exists as a complex (probably a 2:2:2 heterohexamer) with AGT and the proform of PRG2. Interacts with CR2 and VSIG4
Subcellular location: Secreted
PDB structures from and Proteopedia :1C3D (3D)
 1GHQ (3D)
 1W2S (3D)
 2A73 (3D)
 2A74 (3D)
 2GOX (3D)
 2HR0 (3D)
 2I07 (3D)
 2ICE (3D)
 2ICF (3D)
 2NOJ (3D)
 2QKI (3D)
 3D5R (3D)
 3D5S (3D)
 3G6J (3D)
 Post-translational modifications:
C3b is rapidly split in two positions by factor I and a cofactor to form iC3b (inactivated C3b) and C3f which is released. Then iC3b is slowly cleaved (possibly by factor I) to form C3c (beta chain + alpha' chain fragment 1 + alpha' chain fragment 2), C3dg and C3f. Other proteases produce other fragments such as C3d or C3g1
View phosphorylation sites using PhosphoSite2
REFSEQ proteins: NP_000055.2
ENSEMBL proteins: ENSP00000245907
Human Recombinant Proteins Browse Origene for full length recombinant human proteins expressed in human HEK293 cells 
2 Gene Ontology (GO) cellular component terms (links to tree view): | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0005576 | extracellular region |
IEA | -- | | GO:0005615 | extracellular space |
IEA | -- | About this table
Antibodies for C3: Assays for C3: | Protein
Domains/ Families for C3(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
| - Graphical View of Domain Structure for InterPro Entry P01024
ProtoNet protein and cluster: P01024 5 Blocks protein families: IPB001134 Netrin IPB001599 Alpha-2-macroglobulin IPB001840 Anaphylatoxin domain signature IPB002890 Alpha-2-macroglobulin IPB009048 Alpha-macroglobulin
UniProtKB/Swiss-Prot: CO3_HUMAN, P01024Similarity: Contains 1 anaphylatoxin-like domainSimilarity: Contains 1 NTR domain | Gene Function for C3
(According to MGI Jun 06 2009, UniProtKB,
IUBMB,and/or Genatlas,
shRNA from
OriGene,
Sigma-Aldrich, RNAi from
Sigma-Aldrich,
RNAi Products,
Clones, and
Q-PCR Products
from Invitrogen,
Millipore,
OriGene, and/or
Abnova,
siRNAs from
Applied Biosystems,
SYBR primers from OriGene,
Cell-based Assays from Millipore,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000064
Applied Biosystems Silencer® siRNAs for C3
Sigma-Aldrich siRNA for C3  Sigma-Aldrich shRNA for C3  Explore Sigma-Aldrich super-pooled esiRNAs 
              OriGene GFP tagged cDNA clone in CMV expression vector: NM_000064                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000064                                  untagged cDNA clones in CMV expression vector (see all 2): AK094728 
Primers: Browse
Quantitative PCR Central at Invitrogen for Q-PCR LUX™ Primers               OriGene genome-wide validated SYBR primer pairs: NM_000064
UniProtKB/Swiss-Prot: CO3_HUMAN, P01024Function: C3 plays a central role in the activation of the complement system. Its processing by C3 convertase is the central reaction in both classical and alternative complement pathways. After activation C3b can bind covalently, via its reactive thioester, to cell surface carbohydrates or immune aggregatesFunction: Derived from proteolytic degradation of complement C3, C3a anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytesGenatlas biochemistry entry for C3:complement component 3,glycoprotein,180kDa,activated by classical or alternative pathway with two forms,C3a (anaphylatoxin),C3b (opsonin)15/18 MGI mutant phenotypes (inferred from 6 alleles ) (MGI details for C3) (see all 18
):
2 Gene Ontology (GO) molecular function terms (links to tree view): About this table | Pathways & Interactions for C3
(Pathways according to Invitrogen
(maps by GeneGo),
Millipore,
Cell Signaling Technology,
Sigma-Aldrich,
KEGG
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Proteins Network according to
SABiosciences,
Interactions according to 1UniProtKB,
2MINT, and/or
3STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|
3 Sigma-Aldrich "Your Favorite Gene" Pathways for C3 (Your Favorite Gene powered by Ingenuity) 
Gene Network CentralTM Interacting Genes and Proteins Network for C3 
5/51 Interacting proteins for C3 (ENSP000002459073 P010241) via UniProtKB, MINT, and/or STRING (see all 51
)About this table
5/7 Gene Ontology (GO) biological process terms (links to tree view) (see all 7
): | GO ID | Qualified GO term | Evidence | PubMed IDs |
|---|
| GO:0001798 | positive regulation of type IIa hypersensitivity |
IEA | -- | | GO:0006954 | inflammatory response |
IEA | -- | | GO:0006957 | complement activation, alternative pathway |
IEA | -- | | GO:0006958 | complement activation, classical pathway |
IEA | -- | | GO:0007165 | signal transduction |
TAS | 10085065 | About this table
|
Drugs & Compounds for C3(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
Sigma-Aldrich, Tocris Bioscience, and/or
Novoseek and Drugs according to
Enzo Life Sciences and/or
PharmGKB)
About This Section
|
Compounds for C3 available from Tocris Bioscience
| Compound | Action |
CAS
number |
|---|
| Compstatin | C3-binding protein, inhibits complement activation | [206645-99-0] | About this table
10/18 Novoseek chemical compound relationships for C3 gene (see all 18
)
| Compound |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| triacylglycerol |
63.05 |
36 |
8582446 (4), 9555951 (4), 8492712 (3), 8068623 (3) (see all 17) |
| fatty acid |
41.80 |
30 |
11108729 (3), 14703506 (3), 8574269 (2), 9105570 (1) (see all 16) |
| glucose |
41.21 |
96 |
9059512 (8), 8492712 (6), 9130021 (5), 15043507 (3) (see all 34) |
| oleic acid |
35.41 |
10 |
18004729 (2), 8492712 (1), 9034195 (1), 14703506 (1) |
| lipid |
35.07 |
48 |
11836332 (3), 16302015 (3), 17372315 (2), 19022911 (2) (see all 25) |
| cholesterol |
31.36 |
39 |
11714853 (3), 18206145 (2), 18075846 (2), 16302015 (2) (see all 14) |
| neopterin |
29.02 |
3 |
8925815 (1), 7702398 (1), 7874897 (1) |
| glycerol 3-phosphate |
15.77 |
2 |
8582446 (1), 1943492 (1) |
| steroid |
12.07 |
4 |
18615583 (2), 18671285 (1) |
| oxygen |
0.00 |
3 |
1417490 (1), 16099291 (1) |
About this table
1 PharmGKB drug compound relationship for C3 gene
| Drug compound |
PharmGKB Relations |
PubMed IDs for articles supporting these relationships |
| gemfibrozil | PD  GN   | 96192469 | About this table
|
Transcripts for C3(GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 219 Homo sapiens; Jun 2 2009) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
non coding RNAs according to
RNAdb,
ESTs according to GeneTide,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from Invitrogen,
Millipore, and/or
Abnova,
siRNAs from Applied Biosystems,
Sigma-Aldrich,
shRNA from
Sigma-Aldrich,
OriGene,
Tagged/untagged cDNA clones from
OriGene, Expression Assays from Applied Biosystems) About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000064
Sigma-Aldrich siRNA for C3  Sigma-Aldrich shRNA for C3  Explore Sigma-Aldrich super-pooled esiRNAs 
Applied Biosystems Silencer® siRNAs: NM_000064 REFSEQ mRNAs for C3 gene: NM_000064.2
Applied Biosystems TaqMan ® Gene Expression Assays: NM_000064               OriGene GFP tagged cDNA clone in CMV expression vector: NM_000064                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000064                                  untagged cDNA clones in CMV expression vector (see all 2): AK094728  Additional cDNA sequence: AK094728.1 AK304071.1 AY927485.1 BC022897.1 BC063852.1 BC150179.1 BC150200.1 BC150299.1 CR599189.1 CR619237.1 K02765.1 24/35 DOTS entries (see all 35
): DT.95200471 DT.100805138 DT.95212039 DT.100642455 DT.95288012 DT.92469022 DT.100865720 DT.92469028 DT.121504652 DT.100642643 DT.95365044 DT.100668443 DT.86844052 DT.92068615 DT.100668436 DT.92469035 DT.121504611 DT.100668437 DT.40256655 DT.95347307 DT.95356787 DT.95365047 DT.95365050 DT.121504605 24/731 AceView cDNA sequences (see all 731
):CD607286 CR619237 CK429838 AW368852 BM972120 AF064090 AA593902 CB131043 BI823457 AI133409 CD607310 AA345518 AA166723 BM543925 AW368868 BQ013364 BF032613 BQ652672 BQ939823 CA396736 AI093026 AV654754 AA344723 BG567618
highest scoring ESTs for C3:AL531538 AL531541 AL532114 AL557768 AL589340 BQ717819 BX406393 K02765 AA009782 AA025993 Unigene Cluster for C3: Complement component 3 Hs.529053 [show with all ESTs]Unigene Representative Sequence: BC063852
GeneLoc Exon Structure
5/7 Alternative Splicing Database (ASD) splice patterns (SP) for C3 (see all 7
)
| ExUns: | 1 | ^ | 2 | ^ | 3 | ^ | 4 | ^ | 5 | ^ | 6 | ^ | 7 | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11 | ^ | 12 | ^ | 13a | · | 13b | ^ | 14a | · | 14b | ^ | 15 | ^ | 16 | ^ | 17 | ^ | 18a | · | 18b | ^ | 19 | ^ | 20 | ^ | 21 | ^ | 22 | ^ | 23 | ^ | |
| SP1: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |
| SP2: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP4: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP5: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   |
| ExUns: | 24 | ^ | 25 | ^ | 26 | ^ | 27 | ^ | 28 | ^ | 29 | ^ | 30 | ^ | 31 | ^ | 32 | ^ | 33a | · | 33b | ^ | 34a | · | 34b | ^ | 35a | · | 35b | ^ | 36 | ^ | 37 | ^ | 38a | · | 38b | ^ | 39 | ^ | 40 | ^ | 41 | ^ | 42a | · | 42b | |
| SP1: | |   | |   | |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | - |   | - |   | |   | |   | |   | |   | - |   | |   | |   | |   | |   | |   | |
| SP2: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP4: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP5: | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   |
About this scheme
ECgene alternative splicing isoforms for C3
1 Ensembl transcript including schematic representation: ENST00000245907
|
Expression for C3
(Experimental results according to
1GeneNote
and GNF BioGPS,
probe sets-to-genes annotations according to
2GeneAnnot ,
3GeneTide ,
Sets of similar genes according to GeneDecks,
Electronic Northern calculations according to data from
UniGene (Build 219 Homo sapiens),
SAGE tags according to
CGAP,
plus additional links to
SOURCE, and/or
GNF
BioGPS, and/or
EXPOLDB, and/or
UniProtKB,
Expression Assays from
Applied Biosystems
)
About This Section
| C3 expression in normal and diseased human tissues
Applied Biosystems TaqMan ® Gene Expression Assays for C3
1 / 2 / 3 2 probe-sets matching C3 gene Data from
(Publications) and GNF BioGPS About these images About these images
CGAP SAGE TAG: --
SOURCE GeneReport for Unigene cluster: Hs.529053
|
Orthologs for C3
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
and/or
5MGI Jun 06 2009,
with possible further links to
Flybase
and/or
WormBase,
Gene Trees according to Ensembl)
About This Section
|
Orthologs for C3 gene from 5/10 species (see all 10
)
About this table Species with no ortholog for C3
ENSEMBL Gene Tree for C3 | Paralogs for C3(Paralogs according to 1HomoloGene and 2Ensembl, Pseudogenes according to 3Pseudogene.org) About This Section
| Paralogs for C3 gene
- ENSG000002043192 C3P12 ENSG000002043422
|
SNPs/Variants for C3(According to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE, and
UniProtKB,
Linkage Disequilibrium by HapMap,
Genotyping Reagents from
Applied Biosystems)
About This Section
| UniProtKB/Swiss-Prot: CO3_HUMAN, P01024Polymorphism: There are two alleles: C3S (C3 slow), the most common allele in all races and C3F (C3 fast), relatively frequent in Caucasoids, less common in Black Americans, extremely rare in Orientals
HapMap Linkage Disequilibrium images for C3 (up to first 250kb)
|
Disorders & Mutations for C3
(in which this Gene is Involved, According to
OMIM, UniProtKB,
Novoseek, PharmGKB,
Genatlas, GeneTests,
Blood group antigen gene mutations by BGMUT,
HGMD, GAD,
HuGE Navigator,
BCGD,
and/or TGDB.)
About This Section
|
OMIM: 120700 UniProtKB/Swiss-Prot: CO3_HUMAN, P01024
Defects in C3 are the cause of C3 deficiency [MIM:120700]. It can result in susceptibility to pyogenic infection Genetic variation in C3 is associated with susceptibility to age-related macular degeneration type 9 (ARMD9) [MIM:611378]. ARMD is a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane10/36 Novoseek disease relationships for C3 gene (see all 36
)
| Disease |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| complement deficiency |
67.16 |
3 |
18667363 (1) |
| afibrinogenemia |
61.28 |
1 |
1966986 (1) |
| hyperlipidemia familial combined |
57.24 |
3 |
11979403 (2), 11348883 (1) |
| lipodystrophy |
53.02 |
2 |
12942374 (1) |
| glomerulonephritis membranoproliferative |
50.23 |
1 |
8395463 (1) |
| insulin resistance |
47.21 |
19 |
17595349 (3), 16302015 (2), 18206145 (1), 12679444 (1) (see all 10) |
| obesity |
46.82 |
30 |
15853826 (3), 8574269 (2), 1885258 (2), 14564690 (2) (see all 15) |
| meningococcal diseases |
39.83 |
1 |
9844044 (1) |
| insulin sensitivity |
35.60 |
10 |
11397716 (1), 12679444 (1), 15809665 (1), 18702682 (1) (see all 8) |
| dyslipidemia |
31.33 |
5 |
18253759 (1), 11836332 (1), 18680692 (1), 14612209 (1) |
About this table
Genatlas disease: C3 glomerulonephritis,pyogenic recurrent infections,lupus systemic syndrome Human Gene Mutation Database: C3 Genetic Association Database: C3 Human Genome Epidemiology Navigator: C3 (82 documents)
|
Medical News for C3(Possibly Related Articles in
Doctor's Guide)
About This Section
| -- |
Publications for C3 (in
PubMed.
Associations of this gene to articles via
1Novoseek,
2HGNC,
3Entrez Gene,
4UniProtKB/Swiss-Prot,
5UniProtKB/TrEMBL,
6GAD, and/or
7PharmGKB)
About This Section
| 10/414 PubMed articles for C3 gene (see all 414
):- Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (Asp549 to Asn) impairs C3 secretion. (PubMed id 7961791)1, 3, 4 Singer L....Wetsel R.A. (1994)
- The structure of complement C3b provides insights into complement activation and regulation. (PubMed id 17051152)1, 3, 4 Abdul Ajees A.... Murthy H.M.K. (2006)
- Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma. (PubMed id 15278436)1, 3, 6 Hasegawa K....Suzuki Y. (2004)
- [Analysis of heterozygosity levels at P1,TF, PGM1, ACP1, HP, GC, GLO, C3, and ESD loci in pulmonary tuberculosis patients with different treatment outcomes] (PubMed id 11785295)1, 3, 6 Sergeev A.S....Perel'man M.I. (2001)
- Complement C3 variant and the risk of age-related macular degeneration. (PubMed id 17634448)3, 4 Yates J.R.W....Moore A.T. (2007)
- Structure of C3b in complex with CRIg gives insights into regulation of complement activation. (PubMed id 17051150)3, 4 Wiesmann C....van Lookeren Campagne M. (2006)
- Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. (PubMed id 16263699)3, 4 Lewandrowski U.... Sickmann A. (2006)
- Variants in the gene encoding C3 are associated with asthma and related phenotypes among African Caribbean families. (PubMed id 16355111)3, 6 Barnes K.C....Wills-Karp M. (2006)
- Structure of C3b reveals conformational changes that underlie complement activity. (PubMed id 17051160)3, 4 Janssen B.J.C....Gros P. (2006)
- Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. (PubMed id 16335952)3, 4 Liu T.... Smith R.D. (2005)
|
Search for C3
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing C3
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
and/or
H-InvDB)
About This Section
|
| Other Databases showing C3
(According to HUGE)
About This Section
| -- |
Specialized Databases showing C3(According to ATLAS, HORDE, IMGT, MTDB, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| ATLAS Chromosomes in Cancer entry for C3 | Genetics and Cytogenetics in Oncology and Haematology | | C3base | http://bioinf.uta.fi/C3base/ | | GeneReviews | http://www.genetests.org/query?gene=C3 | | Wikipedia | http://en.wikipedia.org/wiki/Complement_c3 | | SeattleSNPs | http://pga.gs.washington.edu/data/c3/ |
|
| | | About This Section
| Licensable Technologies for C3 gene:
| Services for C3(Reagents available from Applied Biosystems, Antibodies and assays by Cell
Signaling Technology, Abcam, Novus Biologicals, Sigma-Aldrich, R&D Systems, Millipore, Abnova, and/or Invitrogen, Clones available from OriGene,and/or Invitrogen, Drugs and/or compounds by Sigma-Aldrich, Enzo Life Sciences, and/or Tocris Bioscience) About This Section
| 
 Products for C3:

 | |
 | | | | |
|
 |  |  |
| | Recombinant Proteins (C3, C3 / C3b, C3c, C3a / C3a des Arg, C3d, C3 / C3a) | | Antibodies (C3, C3 / C3b, C3c, C3a / C3a des Arg, C3d, C3 / C3a) |
| | | Tocris compounds for C3 |
|
 |
 | | | Antibodies for C3 |
| |
GeneCards Homepage - Last full update: 1 Jul 2009
Incremental update: 13 Oct 2009
|